We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELAN icon
901
Elanco Animal Health
ELAN
$13.2B
$557K ﹤0.01%
37,938
-240
-0.6% -$3.34K
DGII icon
902
Digi International
DGII
$2.47B
$555K ﹤0.01%
20,151
+148
+0.7% +$3.9K
CPRI icon
903
Capri Holdings
CPRI
$1.82B
$555K ﹤0.01%
13,071
-3,170
-20% -$111K
TRNS icon
904
Transcat
TRNS
$760M
$555K ﹤0.01%
4,593
+675
+17% +$83.9K
HAS icon
905
Hasbro
HAS
$13.5B
$554K ﹤0.01%
7,657
+166
+2% +$10.8K
TREX icon
906
Trex
TREX
$4.4B
$552K ﹤0.01%
8,297
-1,078
-11% -$75.7K
UGI icon
907
UGI
UGI
$7.87B
$551K ﹤0.01%
22,034
+541
+3% +$13K
AZTA icon
908
Azenta
AZTA
$1.3B
$551K ﹤0.01%
11,379
+679
+6% +$35.3K
TMDX icon
909
Transmedics
TMDX
$2.7B
$548K ﹤0.01%
3,489
+81
+2% +$12.5K
TTEK icon
910
Tetra Tech
TTEK
$8.77B
$547K ﹤0.01%
11,604
+109
+0.9% +$4.85K
LFUS icon
911
Littelfuse
LFUS
$10.4B
$546K ﹤0.01%
2,059
+316
+18% +$81.4K
IP icon
912
International Paper
IP
$22.6B
$545K ﹤0.01%
11,158
-16
-0.1% -$745
TKR icon
913
Timken Company
TKR
$9.19B
$544K ﹤0.01%
6,448
+35
+0.5% +$2.88K
SMFG icon
914
Sumitomo Mitsui Financial
SMFG
$159B
$543K ﹤0.01%
43,030
+2,750
+7% +$36.3K
NSIT icon
915
Insight Enterprises
NSIT
$3.85B
$541K ﹤0.01%
2,513
+119
+5% +$24.5K
LNTH icon
916
Lantheus
LNTH
$6.51B
$540K ﹤0.01%
+4,924
New +$512K
ARW icon
917
Arrow Electronics
ARW
$10.5B
$540K ﹤0.01%
4,067
-803
-16% -$102K
JBTM
918
JBT Marel
JBTM
$7.35B
$539K ﹤0.01%
5,475
+43
+0.8% +$3.97K
BPRN icon
919
Princeton Bancorp
BPRN
$283M
$537K ﹤0.01%
14,525
– –
BEPC icon
920
Brookfield Renewable
BEPC
$5.86B
$535K ﹤0.01%
+16,367
New +$475K
HLIO icon
921
Helios Technologies
HLIO
$2.47B
$534K ﹤0.01%
11,200
-20
-0.2% -$879
VSGX icon
922
Vanguard ESG International Stock ETF
VSGX
$6.34B
$531K ﹤0.01%
8,637
+7,962
+1,180% +$470K
CFR icon
923
Cullen/Frost Bankers
CFR
$10.5B
$531K ﹤0.01%
4,748
+475
+11% +$51.9K
MSTR icon
924
Strategy Inc
MSTR
$34.1B
$530K ﹤0.01%
3,146
-354
-10% -$50.6K
HEI.A icon
925
HEICO Corp Class A
HEI.A
$36B
$528K ﹤0.01%
2,590
-664
-20% -$126K
35 36
37
38 39

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.